BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35892058)

  • 1. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.
    Fahmawi Y; Mehta A; Abdalhadi H; Merritt L; Mizrahi M
    Transl Gastroenterol Hepatol; 2022; 7():30. PubMed ID: 35892058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis.
    Armellini E; Facciorusso A; Crinò SF
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837560
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis.
    Khoury T; Sbeit W; Fusaroli P; Campana D; Brighi N; Napoleon B; Lisotti A
    Dig Endosc; 2024 Apr; 36(4):395-405. PubMed ID: 37702096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review.
    El Sayed G; Frim L; Franklin J; McCrudden R; Gordon C; Al-Shamma S; Kiss S; Hegyi P; Erőss B; Hegyi PJ
    Therap Adv Gastroenterol; 2021; 14():17562848211042171. PubMed ID: 34819995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
    Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
    Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of endoscopic ultrasound-guided ablation therapy for solid pancreatic tumors: a systematic review.
    Zhang L; Tan S; Huang S; Zhong C; Lü M; Peng Y; Tang X
    Scand J Gastroenterol; 2020 Sep; 55(9):1121-1131. PubMed ID: 32730715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
    Garg R; Mohammed A; Singh A; Harnegie MP; Rustagi T; Stevens T; Chahal P
    Endosc Ultrasound; 2022; 11(3):170-185. PubMed ID: 35313416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
    Borrelli de Andreis F; Boškoski I; Mascagni P; Schepis T; Bianchi A; Schinzari G; Annicchiarico BE; Quero G; Tortora G; Alfieri S; Gasbarrini A; Costamagna G; Spada C; Attili F
    Pancreatology; 2023 Aug; 23(5):543-549. PubMed ID: 37236853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
    Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
    Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease: an observational prospective multicenter study.
    Figueiredo Ferreira M; Garces-Duran R; Eisendrath P; Devière J; Deprez P; Monino L; Van Laethem JL; Borbath I
    Endosc Int Open; 2022 Oct; 10(10):E1380-E1385. PubMed ID: 36262511
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of EUS-RFA in pancreatic tumors: Is it ready for prime time? A systematic review and meta-analysis.
    Dhaliwal A; Kolli S; Dhindsa BS; Choa J; Mashiana HS; Ramai D; Chandan S; Bhogal N; Sayles H; Bhat I; Singh S; Adler DG
    Endosc Int Open; 2020 Oct; 8(10):E1243-E1251. PubMed ID: 33015325
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study.
    Barthet M; Giovannini M; Lesavre N; Boustiere C; Napoleon B; Koch S; Gasmi M; Vanbiervliet G; Gonzalez JM
    Endoscopy; 2019 Sep; 51(9):836-842. PubMed ID: 30669161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature.
    Imperatore N; de Nucci G; Mandelli ED; de Leone A; Zito FP; Lombardi G; Manes G
    Endosc Int Open; 2020 Dec; 8(12):E1759-E1764. PubMed ID: 33269308
    [No Abstract]   [Full Text] [Related]  

  • 14. Endoscopic ablation therapy for the pancreatic neoplasms.
    Matsumoto K; Kato H
    Dig Endosc; 2023 May; 35(4):430-442. PubMed ID: 36366955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions.
    Karaisz FG; Elkelany OO; Davies B; Lozanski G; Krishna SG
    Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
    Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUS-RFA of the pancreas: where are we and future directions.
    Gollapudi LA; Tyberg A
    Transl Gastroenterol Hepatol; 2022; 7():18. PubMed ID: 35548478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic ultrasound-guided ablation of solid pancreatic lesions: A systematic review of early outcomes with pooled analysis.
    Spadaccini M; Di Leo M; Iannone A; von den Hoff D; Fugazza A; Galtieri PA; Pellegatta G; Maselli R; Anderloni A; Colombo M; Siersema PD; Carrara S; Repici A
    World J Gastrointest Oncol; 2022 Feb; 14(2):533-542. PubMed ID: 35317325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and Safety of EUS Ablation Techniques for Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis.
    Papaefthymiou A; Johnson GJ; Maida M; Gkolfakis P; Ramai D; Facciorusso A; Arvanitakis M; Ney A; Fusai GK; Saftoiu A; Tabacelia D; Phillpotts S; Chapman MH; Webster GJ; Pereira SP
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series.
    de Nucci G; Imperatore N; Mandelli ED; di Nuovo F; d'Urbano C; Manes G
    Endosc Int Open; 2020 Dec; 8(12):E1754-E1758. PubMed ID: 33269307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.